Eugene E. Wright

2.8k total citations · 1 hit paper
48 papers, 1.7k citations indexed

About

Eugene E. Wright is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Eugene E. Wright has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Eugene E. Wright's work include Diabetes Management and Research (29 papers), Diabetes Treatment and Management (28 papers) and Pancreatic function and diabetes (12 papers). Eugene E. Wright is often cited by papers focused on Diabetes Management and Research (29 papers), Diabetes Treatment and Management (28 papers) and Pancreatic function and diabetes (12 papers). Eugene E. Wright collaborates with scholars based in United States, United Kingdom and Hong Kong. Eugene E. Wright's co-authors include Irl B. Hirsch, Rattan Juneja, Jay H. Shubrook, Vincent Wai‐Sun Wong, Kenneth Cusi, Caryl J. Antalis, John M. Beals, Eden Miller, Rohit Loomba and Robert H. Eckel and has published in prestigious journals such as Gastroenterology, Endocrine Reviews and Diabetes.

In The Last Decade

Eugene E. Wright

44 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease

2021 357 citations Jay H. Shubrook, Eugene E. Wright et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eugene E. Wright United States	16	973	464	388	296	228	48	1.7k
Lutgarda Bozzetto Italy	25	1.0k 1.0×	471 1.0×	271 0.7×	292 1.0×	215 0.9×	83	2.1k
A J Scheen Belgium	12	732 0.8×	436 0.9×	318 0.8×	293 1.0×	79 0.3×	32	1.4k
Antonella Mosca Italy	23	848 0.9×	1.5k 3.3×	485 1.3×	294 1.0×	116 0.5×	82	2.1k
A B Olokoba Nigeria	9	458 0.5×	220 0.5×	196 0.5×	275 0.9×	83 0.4×	35	1.2k
Giovanni Annuzzi Italy	30	1.4k 1.5×	678 1.5×	455 1.2×	386 1.3×	213 0.9×	114	2.9k
Angelo Maria Patti Italy	26	801 0.8×	239 0.5×	459 1.2×	506 1.7×	85 0.4×	58	1.8k
Rosaria Vincenza Giglio Italy	30	701 0.7×	544 1.2×	560 1.4×	582 2.0×	60 0.3×	91	2.5k
Eleonora Scorletti United Kingdom	24	954 1.0×	1.7k 3.7×	268 0.7×	482 1.6×	79 0.3×	52	2.3k
Lea Duvnjak Croatia	21	686 0.7×	266 0.6×	274 0.7×	347 1.2×	191 0.8×	107	1.8k
Lateefat B. Olokoba Nigeria	7	456 0.5×	187 0.4×	165 0.4×	267 0.9×	78 0.3×	17	1.1k

Countries citing papers authored by Eugene E. Wright

Since Specialization

Citations

This map shows the geographic impact of Eugene E. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene E. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene E. Wright more than expected).

Fields of papers citing papers by Eugene E. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene E. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene E. Wright. The network helps show where Eugene E. Wright may publish in the future.

Co-authorship network of co-authors of Eugene E. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene E. Wright. A scholar is included among the top collaborators of Eugene E. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene E. Wright. Eugene E. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

SKOLNIK, NEIL, et al.. (2026). Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease. Gastroenterology.

Wright, Eugene E., et al.. (2025). Prescribed Total Daily Insulin Dose and Predictors of Insulin Dose for Adults with Type 2 Diabetes on Multiple Daily Injections of Insulin: A Retrospective Cohort Study. Diabetology. 6(2). 13–13. 1 indexed citations

Wright, Eugene E., et al.. (2025). Addition of continuous glucose monitoring to glucagon-like peptide 1 receptor agonist treatment for type 2 diabetes mellitus – An economic evaluation. Journal of Managed Care & Specialty Pharmacy. 31(2). 127–136.

Wright, Eugene E., Ana María Cebrián Cuenca, & Daniel Ngui. (2025). A primary care guide to the screening and pharmacologic management of chronic kidney disease in people living with type 2 diabetes. Primary care diabetes. 19(5). 411–421.

Wright, Eugene E. & Susanne B. Nicholas. (2024). Making treatment guideline recommendations in chronic kidney disease and type 2 diabetes more accessible to primary care providers in the United States. Postgraduate Medicine. 136(4). 347–357. 2 indexed citations

Wright, Eugene E., Gregory J. Roberts, Joyce Chuang, et al.. (2024). Initiating GLP-1 Therapy in Combination with FreeStyle Libre Provides Greater Benefit Compared with GLP-1 Therapy Alone. Diabetes Technology & Therapeutics. 26(10). 754–762. 10 indexed citations

Kolkhof, Peter, et al.. (2024). Summary of Research: Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease—The FIDELITY Pooled Analysis. Diabetes Therapy. 15(9). 1861–1864. 3 indexed citations

Miller, Eden, Joyce Chuang, Gregory J. Roberts, et al.. (2024). Association of Changes in A1C Following Continuous Glucose Monitoring Acquisition in People with Sub-Optimally Treated Type 2 Diabetes Taking GLP-1 RA Therapy. Diabetes Therapy. 15(9). 2027–2038. 4 indexed citations

Handelsman, Yehuda, Javed Butler, George L. Bakris, et al.. (2023). Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases. Journal of Diabetes and its Complications. 37(2). 108389–108389. 43 indexed citations

10.

Kelepouris, Ellie, Wendy L. St. Peter, Joshua J. Neumiller, & Eugene E. Wright. (2023). Optimizing Multidisciplinary Care of Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus. Diabetes Therapy. 14(7). 1111–1136. 13 indexed citations

11.

Wright, Eugene E. & Savitha Subramanian. (2023). Is Continuous Glucose Monitoring a Tool, an Intervention, or Both?. Diabetes Technology & Therapeutics. 25(3_suppl). S48–S55. 4 indexed citations

12.

Shubrook, Jay H., Joshua J. Neumiller, & Eugene E. Wright. (2021). Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations. Postgraduate Medicine. 134(4). 376–387. 25 indexed citations

13.

Ajjan, Ramzi, et al.. (2019). Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners. Advances in Therapy. 36(3). 579–596. 71 indexed citations

14.

Wright, Eugene E., et al.. (2017). Hot Topics in Primary Care: Demystifying the Differences: Follow-on Biologics, Biosimilars, and Generics.. PubMed. 66(4 Suppl). S22–S27. 1 indexed citations

15.

Singh, Sonal, Eugene E. Wright, Anita Y. M. Kwan, et al.. (2016). Glucagon‐like peptide‐1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 19(2). 228–238. 67 indexed citations

16.

Anderson, John E., Eugene E. Wright, & Charles F. Shaefer. (2016). Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus. Diabetes Therapy. 8(1). 33–53. 14 indexed citations

17.

Wright, Eugene E., Anthony H. Stonehouse, & Robert Cuddihy. (2010). In support of an early polypharmacy approach to the treatment of type 2 diabetes. Diabetes Obesity and Metabolism. 12(11). 929–940. 22 indexed citations

18.

Wright, Eugene E., et al.. (2006). Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. International Journal of Clinical Practice. 60(3). 308–314. 418 indexed citations

19.

Wright, Eugene E., et al.. (2000). Introduction of a Switch that Can Reverse Blood Flow Direction On-Line during Hemodialysis. ASAIO Journal. 46(4). 464–468. 5 indexed citations

20.

Wright, Eugene E.. (1988). Catheter care: the risk of infection.. PubMed. 3(12). 487–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact